AI Drug Firm METiS Considering $200 Million Hong Kong IPO, Sources Say
(Bloomberg) -- Artificial intelligence-driven drug firm METiS Pharmaceuticals is considering an initial public offering in Hong Kong to raise as much as $200 million, according to people familiar with the matter. Most Read from Bloomberg The drug delivery …